Insights On Pharmaceutical Inspection

  1. EU And PIC/S Annex 1: CCS Shortfalls After 2 Years Of Implementation 4/16/2026

    Explore how to elevate Contamination Control Strategies from static documents to inspection-ready, lifecycle tools, as well as practical approaches to Annex 1 compliance and risk-based CCS development.

  2. Mastering Material Transfer: Keeping Contamination Out Of Your Cleanroom 4/20/2026

    Master the nuances of material transfer through expert-led training. Learn to assess packaging integrity, ensure complete disinfection coverage, and manage time-sensitive items with precision.

  3. Ensuring Consistent Quality In Pharmaceutical Water For Injection (WFI) Systems Presentation 3/5/2026

    Maintaining high-purity water is vital for pharmaceutical production. Explore key strategies for system design, risk mitigation, and rigorous process control to ensure consistent regulatory compliance.

  4. Managing Risk In The Most Complex Combination Device Format 2/18/2026

    Autoinjectors add mechanical forces and interactions that change how container closure integrity must be evaluated. Learn why device complexity creates new risks and how testing strategies must adapt.

  5. ICP-MS And ICP-OES: Tools For Elemental Impurity Analysis 12/11/2024

    Leverage advanced elemental impurity testing methods to ensure the safety, compliance, and accuracy of your drug products throughout the manufacturing process.

  6. USP Draft Chapters On CCS: What You Need To Know 5/12/2026

    Learn why it's important to stay aligned with evolving Annex 1 expectations to support sterility assurance, regulatory compliance, and patient safety across sterile drug manufacturing operations.

  7. Integrity Testing Of Inhaler Products 1/5/2026

    Ensuring inhaler integrity is vital for patient safety and regulatory compliance. Discover how Vacuum decay testing provides a sensitive, non-destructive method to detect leaks and maintain sterility.

  8. Lessons From FDA 483s And Warning Letters: Cleanroom Compliance 12/8/2025

    Learn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.

  9. Why Is It Important To Have Properly Trained Visual Inspectors? 8/4/2025

    Properly trained visual inspectors are crucial for identifying defects in parenteral drugs, safeguarding patient safety and product quality.

  10. Enhanced Flow Kit Performance With Leak And PUPSIT Testing 1/13/2026

    Sterile drug filtration demands rigorous integrity testing to prevent contamination. Learn how PUPSIT and in situ leak testing strengthen compliance with EU GMP Annex 1 and ensure reliable manufacturing.